181 related articles for article (PubMed ID: 29772159)
1. High Titer of Circulating Antiglutamic Acid Decarboxylase Antibodies in a Patient with Cerebellar Ataxia and Type 1 Diabetes.
Kataria R; Fernandes S; Lebastchi J; Bravo CA; Sena KN
Conn Med; 2017 Mar; 81(3):161-164. PubMed ID: 29772159
[TBL] [Abstract][Full Text] [Related]
2. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
[TBL] [Abstract][Full Text] [Related]
3. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients.
Honnorat J; Saiz A; Giometto B; Vincent A; Brieva L; de Andres C; Maestre J; Fabien N; Vighetto A; Casamitjana R; Thivolet C; Tavolato B; Antoine J; Trouillas P; Graus F
Arch Neurol; 2001 Feb; 58(2):225-30. PubMed ID: 11176960
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity.
Saiz A; Arpa J; Sagasta A; Casamitjana R; Zarranz JJ; Tolosa E; Graus F
Neurology; 1997 Oct; 49(4):1026-30. PubMed ID: 9339684
[TBL] [Abstract][Full Text] [Related]
5. [A new case of cerebellar ataxia with anti-GAD antibodies treated with corticosteroids and initially seronegative].
Birand B; Cabre P; Bonnan M; Olindo S; Smadja D
Rev Med Interne; 2006 Aug; 27(8):616-9. PubMed ID: 16797794
[TBL] [Abstract][Full Text] [Related]
6. Low-titer anti-GAD-antibody-positive cerebellar ataxia.
Nanri K; Niwa H; Mitoma H; Takei A; Ikeda J; Harada T; Okita M; Takeguchi M; Taguchi T; Mizusawa H
Cerebellum; 2013 Apr; 12(2):171-5. PubMed ID: 22923147
[TBL] [Abstract][Full Text] [Related]
7. Stiff-person syndrome associated with cerebellar ataxia and high glutamic acid decarboxylase antibody titer.
Kono S; Miyajima H; Sugimoto M; Suzuki Y; Takahashi Y; Hishida A
Intern Med; 2001 Sep; 40(9):968-71. PubMed ID: 11579968
[TBL] [Abstract][Full Text] [Related]
8. A patient with type 1 diabetes mellitus and cerebellar ataxia associated with high titer of circulating anti-glutamic acid decarboxylase antibodies.
Iwasaki H; Sato R; Shichiri M; Hirata Y
Endocr J; 2001 Apr; 48(2):261-8. PubMed ID: 11456277
[TBL] [Abstract][Full Text] [Related]
9. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
[TBL] [Abstract][Full Text] [Related]
10. Low-Titre GAD Antibody-Associated Late-Onset Cerebellar Ataxia with a Significant Clinical Response to Intravenous Immunoglobulin Treatment.
Petrijan T; Menih M
Cerebellum; 2017 Aug; 16(4):868-871. PubMed ID: 28321713
[TBL] [Abstract][Full Text] [Related]
11. Lesson of the month 2: Autoimmune sequelae of anti-GAD antibodies - thinking outside the box.
Ward RJ; Varughese GI; Jose B; Abraham RJ
Clin Med (Lond); 2017 Oct; 17(5):473-474. PubMed ID: 28974603
[TBL] [Abstract][Full Text] [Related]
12. Acute Cerebellar Ataxia Associated with Anti-glutamic Acid Decarboxylase Antibodies Mimicking Miller Fisher Syndrome.
Nakamura Y; Nakajima H; Hosokawa T; Yamane K; Ishida S; Kimura F
Intern Med; 2018 Jan; 57(2):269-271. PubMed ID: 29093402
[TBL] [Abstract][Full Text] [Related]
13. Cerebellar ataxia and epilepsy with anti-GAD antibodies: treatment with IVIG and plasmapheresis.
Georgieva Z; Parton M
BMJ Case Rep; 2014 Jan; 2014():. PubMed ID: 24419643
[TBL] [Abstract][Full Text] [Related]
14. Acute Cerebellar Ataxia Associated with Modest Elevation of Anti-GAD Antibodies in a Young Patient.
Gomez J; Jin D
Tremor Other Hyperkinet Mov (N Y); 2018; 8():620. PubMed ID: 30647991
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous downbeat nystagmus as a clue for the diagnosis of ataxia associated with anti-GAD antibodies.
Vale TC; Pedroso JL; Alquéres RA; Dutra LA; Barsottini OG
J Neurol Sci; 2015 Dec; 359(1-2):21-3. PubMed ID: 26671081
[TBL] [Abstract][Full Text] [Related]
16. Transient Neurological Symptoms Preceding Cerebellar Ataxia with Glutamic Acid Decarboxylase Antibodies.
Muñiz-Castrillo S; Vogrig A; Joubert B; Pinto AL; Gonçalves D; Chaumont H; Rogemond V; Picard G; Fabien N; Honnorat J
Cerebellum; 2020 Oct; 19(5):715-721. PubMed ID: 32592031
[TBL] [Abstract][Full Text] [Related]
17. A Case of Treatment Resistance and Complications in a Patient with Stiff Person Syndrome and Cerebellar Ataxia.
Jones LA; Baber W; Wardle M; Robertson NP; Morris HR; Church A; Llewelyn JG; Peall KJ
Tremor Other Hyperkinet Mov (N Y); 2019; 9():. PubMed ID: 31646058
[TBL] [Abstract][Full Text] [Related]
18. Cerebellar ataxia and autoantibodies restricted to glutamic acid decarboxylase 67 (GAD67).
Guasp M; Solà-Valls N; Martínez-Hernández E; Gil MP; González C; Brieva L; Saiz A; Dalmau J; Graus F; Ariño H
J Neuroimmunol; 2016 Nov; 300():15-17. PubMed ID: 27806870
[TBL] [Abstract][Full Text] [Related]
19. Type 1 diabetes mellitus and drug-resistant epilepsy: presence of high titer of anti-glutamic acid decarboxylase autoantibodies in serum and cerebrospinal fluid.
Yoshimoto T; Doi M; Fukai N; Izumiyama H; Wago T; Minami I; Uchimura I; Hirata Y
Intern Med; 2005 Nov; 44(11):1174-7. PubMed ID: 16357456
[TBL] [Abstract][Full Text] [Related]
20. Cortical dysfunction in cerebellar ataxia with antibodies to glutamic acid decarboxylase.
Simon NG; Vucic S; Joffe R; Kiernan MC
J Neurol; 2014 Jan; 261(1):238-9. PubMed ID: 24292643
[No Abstract] [Full Text] [Related]
[Next] [New Search]
